Published August 19, 2003 | Version v1
Patent Open

Use of methylnaltrexone and related compounds

Description

A method for preventing or treating opioid induced changes in gastrointestinal motility. The method comprises administering methylnaltrexone or another quaternary derivative of noroxymorphone to a patient prior to the administration of an opioid or after the onset of side effects induced by the administration of an opioid, wherein the methylnaltrexone or quaternary derivative is administered orally in an enterically coated form.

Files

US6608075.pdf

Files (498.5 kB)

Name Size Download all
md5:3b470388d12bb352662bcdac512fd7e0
498.5 kB Preview Download

Additional details

Identifiers

Patent application number
US 86216901 A
Patent number
US 6608075 B2
Other
oai:uchicago.tind.io:9416

Dates

Patent filed
2001-05-21

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Anesthesia and Critical Care